| Schedule of Segment Information |
The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
Collaboration and license revenue |
$ |
1,051 |
|
|
$ |
3,076 |
|
|
$ |
2,033 |
|
|
$ |
5,247 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Research and development: |
|
|
|
|
|
|
|
|
|
|
|
Personnel expenses |
|
6,909 |
|
|
|
8,966 |
|
|
|
15,240 |
|
|
|
17,782 |
|
Facility-related and other |
|
5,367 |
|
|
|
5,657 |
|
|
|
9,932 |
|
|
|
11,205 |
|
Laboratory supplies, research materials and studies |
|
5,297 |
|
|
|
12,101 |
|
|
|
9,575 |
|
|
|
21,590 |
|
Clinical studies |
|
4,017 |
|
|
|
3,721 |
|
|
|
6,907 |
|
|
|
7,416 |
|
Stock-based compensation |
|
1,197 |
|
|
|
1,668 |
|
|
|
2,428 |
|
|
|
3,406 |
|
Depreciation expense |
|
615 |
|
|
|
521 |
|
|
|
1,224 |
|
|
|
1,023 |
|
General and administrative: |
|
|
|
|
|
|
|
|
|
|
|
Personnel expenses |
|
2,604 |
|
|
|
3,337 |
|
|
|
6,121 |
|
|
|
6,356 |
|
Legal and professional fees |
|
2,520 |
|
|
|
2,041 |
|
|
|
4,212 |
|
|
|
3,995 |
|
Facility-related and other |
|
1,774 |
|
|
|
1,935 |
|
|
|
3,464 |
|
|
|
3,743 |
|
Stock-based compensation |
|
1,160 |
|
|
|
1,606 |
|
|
|
2,394 |
|
|
|
3,281 |
|
Depreciation expense |
|
84 |
|
|
|
176 |
|
|
|
168 |
|
|
|
353 |
|
Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
|
Interest and other income, net |
|
833 |
|
|
|
2,390 |
|
|
|
1,995 |
|
|
|
5,192 |
|
Interest expense |
|
(699 |
) |
|
|
(689 |
) |
|
|
(1,388 |
) |
|
|
(1,368 |
) |
Net loss |
$ |
(30,359 |
) |
|
$ |
(36,952 |
) |
|
$ |
(59,025 |
) |
|
$ |
(71,079 |
) |
|